Neurocrine Biosciences (NBIX) Work In Process (2017 - 2025)

Neurocrine Biosciences has reported Work In Process for 9 years, with the latest figure at $13.8 million in Q1 2025.

• For the quarter ending Q1 2025, Work In Process rose 15.0% year-over-year to $13.8 million; the trailing twelve-month figure through Mar 2025 stood at $13.8 million (up 15.0% YoY), and the FY2024 full-year result was $10.9 million, up 12.37% from the prior year.
• Work In Process for Q1 2025 stood at $13.8 million, up from $10.9 million in the prior quarter.
• The five-year high for Work In Process was $13.8 million in Q1 2025, with the low at $3.6 million in Q4 2021.
• Historically, Work In Process has averaged $9.8 million across 5 years, with a median of $10.8 million in 2024.
• Annual changes were most pronounced in 2023 — Work In Process soared 73.21% — and 2024, when it grew 12.37%.
• Neurocrine Biosciences' Work In Process stood at $3.6 million in 2021, then surged by 55.56% to $5.6 million in 2022, then jumped by 73.21% to $9.7 million in 2023, then gained by 12.37% to $10.9 million in 2024, then gained by 26.61% to $13.8 million in 2025.
• The last three Work In Process figures came in at $13.8 million (Q1 2025), $10.9 million (Q4 2024), and $10.6 million (Q3 2024), per Business Quant data.